The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Personalized biomarker-based treatment strategy in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Results of the biomarker-driven cohorts of the EORTC-HNCG-1559 trial (UPSTREAM).
 
Rachel Galot
Speakers' Bureau - BMS (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Lilly; MSD; MSD; MSD Oncology
 
Christophe Le Tourneau
Honoraria - Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Merck Serono; MSD; Nanobiotix; Novartis; Rakuten Medical; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck Serono; MSD; Nanobiotix; Roche; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD
 
Lisa Licitra
Honoraria - ALTIS Omnia Pharma Service Srl; Bristol Mayers Squibb [K.K.]; Merck KGaA; Merck Serono; MSD IT
Consulting or Advisory Role - Abbvie S.r.l.; ALX Oncology; Bicara Therapeutics; Boehringer Ingelheim; EMD Ser Reaserach & Development Institute Inc.; Genmab; GlaxoSmithKline; GroupH Ltd; Janssen Research & Development; Medscape LLC; Merck Healtcare KGaA; Merck Serono; MSD; MSD; Purple Biotech; Roche; Seagan
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Debiopharm Group (Inst); Eisai (Inst); Exelixis (Inst); IRX Therapeutics (Inst); Medpace (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Roche (Inst)
Travel, Accommodations, Expenses - TAE Life Sciences
 
Joel Guigay
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Innate Pharma; Merck Serono
Research Funding - Bristol-Myers Squibb (Inst); Merck Serono (Inst)
 
Anthony Kong
Consulting or Advisory Role - Avvinity Therapeutics; MSD
Speakers' Bureau - Bristol-Myers Squibb; Merck; MSD
Research Funding - AstraZeneca (Inst); PUMA therapeutics (Inst)
 
Inge Tinhofer
Honoraria - Merck KGaA
 
Caroline Even
Consulting or Advisory Role - Bristol-Myers Squibb; Fstar Therapeutics (Inst); GlaxoSmithKline (Inst); Innate Pharma; Merck Serono; Merus (Inst); MSD Oncology; Novartis (Inst)
Travel, Accommodations, Expenses - Merck Serono; Merck Serono; MSD Oncology
 
Amaury Daste
Consulting or Advisory Role - BMS; Merck; Merus; MSD
Travel, Accommodations, Expenses - BMS; Merck
 
Esma Saada-Bouzid
No Relationships to Disclose
 
Frederic Rolland
Consulting or Advisory Role - Eisai; Ipsen; Merck KGaA; MSD Oncology; Pfizer
Travel, Accommodations, Expenses - Ipsen; Merck KGaA; Merck KGaA; MSD Oncology; Mundipharma; Pfizer
 
Stephanie Henry
Consulting or Advisory Role - AstraZeneca; bioteqPartner; BMSi; Eisai; Gilead Sciences; GlaxoSmithKline; Merck; MSD Oncology; Novartis; Sanofi
Travel, Accommodations, Expenses - GlaxoSmithKline; MSD Oncology; Roche; Teva
 
Sylvie Rottey
Consulting or Advisory Role - BMS GmbH & Co. KG (Inst); Ipsen (Inst); Janssen (Inst); MSD (Inst); Pfizer (Inst)
Speakers' Bureau - BMS GmbH & Co. KG (Inst); Ipsen (Inst); Roche (Inst)
Research Funding - BMS GmbH & Co. KG (Inst)
Travel, Accommodations, Expenses - Merck (Inst); MSD (Inst)
 
Emmanuel Seront
No Relationships to Disclose
 
Annemie Rutten
No Relationships to Disclose
 
Philip Debruyne
Leadership - Dr. Philip Debruyne (BV)
Stock and Other Ownership Interests - Alkermes; Biocartis; Dr. Philip Debruyne (BV); Mural Oncology PLC
Honoraria - Astellas Pharma; Ipsen; MSD
 
Konstantina Tsechilidou
No Relationships to Disclose
 
Catherine Fortpied
No Relationships to Disclose
 
Ana Joaquim
No Relationships to Disclose
 
Anne-sophie Govaerts
No Relationships to Disclose
 
Jean-Pascal Machiels
Consulting or Advisory Role - ALX Oncology; ANAVEON (Inst); Astellas Pharma (Inst); AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; CUE Biopharma; CureVac (Inst); eTHERNA; F-star; Genmab (Inst); GlaxoSmithKline (Inst); Incyte; Innate Pharma; IPSEN (Inst); ITeos Therapeutics; Janssen; Merck Serono; Merus (Inst); MSD Oncology (Inst); NEKTAR; Novartis; Pfizer; Roche; Seagen (Inst); Seagen (Inst)
Research Funding - Bayer; Janssen; Novartis; Sanofi
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Gilead Sciences; Merck Serono (Inst); MSD; Pfizer
Other Relationship - PsiOxus Therapeutics